MCID: BNG002
MIFTS: 28

Benign Meningioma malady

Categories: Genetic diseases, Cancer diseases, Neuronal diseases, Rare diseases, Endocrine diseases

Aliases & Classifications for Benign Meningioma

About this section

Aliases & Descriptions for Benign Meningioma:

Name: Benign Meningioma 10 47 12 65
 
Meningioma, Benign 10

Classifications:



External Ids:

Disease Ontology10 DOID:4587
MeSH36 D008579
NCIt42 C4055
UMLS65 C0281784

Summaries for Benign Meningioma

About this section
MalaCards based summary: Benign Meningioma, also known as meningioma, benign, is related to meningioma, familial and pulmonary sclerosing hemangioma. An important gene associated with Benign Meningioma is NF2 (Neurofibromin 2 (Merlin)). Affiliated tissues include brain, endothelial and breast.

Related Diseases for Benign Meningioma

About this section

Diseases in the Benign Meningioma family:

Meningioma, Familial Familial Multiple Meningioma

Diseases related to Benign Meningioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 78)
idRelated DiseaseScoreTop Affiliating Genes
1meningioma, familial10.4
2pulmonary sclerosing hemangioma10.4NF2, PGR
3pituitary stalk meningioma10.4NF2, PGR
4corneal neovascularization10.4NF2, PGR
5pyelonephritis10.4NF2, PGR
6skull base meningioma10.4NF2, PGR
7fibrous meningioma10.4MKI67, NF2
8third ventricle chordoid glioma10.4NF2, TERT
9breast papillomatosis10.4MKI67, PGR
10rectum mucinous adenocarcinoma10.4MKI67, PGR
11ovarian clear cell adenocarcinoma10.3MKI67, PGR
12immune system cancer10.3MKI67, PGR
13osteoblastoma10.3MKI67, PGR
14lymphoplasmacyte-rich meningioma10.3MKI67, NF2
15uterine inflammatory disease10.3CTSL, TERT
16uterine corpus adenosarcoma10.3BIRC5, PGR
17intracerebral cystic meningioma10.2NF2, PGR
18breast leiomyoma10.2MKI67, PGR
19male reproductive organ benign neoplasm10.2NF2, PGR
20deep leiomyoma10.2PCNA, PGR
21vitreous detachment10.2CTSL, TERT
22dermato-cardio-skeletal syndrome, borrone type10.2BIRC5, TERT
23autosomal dominant complex spastic paraplegia type 9a10.2BIRC5, MKI67
24distal monosomy 9p10.2BIRC5, NF2
25familial short qt syndrome10.2BIRC5, NF2
26oral lichen planus10.2MKI67, PCNA
27locked-in syndrome10.2NF2, PCNA
28grayson-wilbrandt corneal dystrophy10.2PCNA, PGR
29selective igg deficiency disease10.1MKI67, PCNA
30bowenoid papulosis10.1MKI67, PCNA
31prostatic cyst10.1PCNA, PGR
32progressive muscular atrophy10.1MKI67, PCNA
33levator syndrome10.1MKI67, PCNA
34cervical adenoid cystic carcinoma10.1PCNA, PGR
35preretinal fibrosis10.1NF2, PCNA
36retinitis10.0
37larynx sarcoma10.0MKI67, PGR
38cervical ribs, sprengel anomaly, anal atresia, and urethral obstruction10.0BIRC5, MKI67, TERT
39desmoplastic infantile astrocytoma10.0MKI67, PCNA
40uterine corpus endometrial stromal sarcoma9.9PCNA, PGR
41juxtacortical chondroma9.9MKI67, PCNA, TERT
42myoclonic cerebellar dyssynergia9.9MKI67, PGR
43bone ameloblastoma9.9PCNA, TERT
44rheumatoid arthritis9.9
45neuroblastoma9.9
46lung cancer9.9
47breast cancer9.9
4817-alpha-hydroxylase/17,20-lyase deficiency9.9
49otitis media9.9
50peutz-jeghers syndrome9.9

Graphical network of the top 20 diseases related to Benign Meningioma:



Diseases related to benign meningioma

Symptoms for Benign Meningioma

About this section

Drugs & Therapeutics for Benign Meningioma

About this section

Drugs for Benign Meningioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 12)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
HydroxyureaapprovedPhase 2188127-07-13657
Synonyms:
1-HYDROXYUREA
127-07-1
4-03-00-00170 (Beilstein Handbook Reference)
55291_FLUKA
AC1L1GF8
AC1Q4ZXK
AI3-51139
BB_SC-7256
BRN 1741548
BSPBio_002164
Bio1_000451
Bio1_000940
Bio1_001429
Biosupressin
C07044
CCRIS 958
CHEBI:44423
CHEMBL467
CID3657
Carbamohydroxamic Acid
Carbamohydroxamic acid
Carbamohydroximic Acid
Carbamohydroximic acid
Carbamohydroxyamic Acid
Carbamohydroxyamic acid
Carbamoyl Oxime
Carbamoyl oxime
Carbamyl Hydroxamate
Carbamyl hydroxamate
Carrbamoyl Oxime
D00341
D006918
DB01005
DRG-0253
DivK1c_000556
Droxia
Droxia (TM)
Droxia (TN)
E0723DBA-5AF3-49D1-B5F6-59420AB87AC9
EINECS 204-821-7
EU-0100596
FT-0083575
H 8627
H0310
H20210
H8627_SIGMA
HMS1920F09
HMS2091L17
HMS501L18
HSDB 6887
HU
HYDREA (TN)
HYDROXY-UREA
Hidrix
Hidroxicarbamida
Hidroxicarbamida [INN-Spanish]
Hydrea
Hydrea (TM)
Hydrea, Biosupressin, Cytodrox, Hydroxyurea
Hydreia
Hydroxicarbamidum
Hydroxycarbamid
Hydroxycarbamide
Hydroxycarbamide (JAN/INN)
Hydroxycarbamidum
Hydroxycarbamidum [INN-Latin]
Hydroxycarbamine
Hydroxyharnstoff
Hydroxyharnstoff [German]
Hydroxylurea
Hydroxyurea
Hydroxyurea (D4)
Hydroxyurea (USP)
Hydroxyurea [USAN:BAN]
Hydroxyurea(d4)
 
Hydura
Hydurea
I05-0250
IDI1_000556
Idrossicarbamide
Idrossicarbamide [DCIT]
Idrossicarbamide [Dcit]
KBio1_000556
KBio2_001389
KBio2_003957
KBio2_006525
KBio3_001384
KBioGR_000383
KBioSS_001389
LS-709
Litaler
Litalir
Lopac-H-8627
Lopac0_000596
MLS001332381
MLS001332382
MLS002153389
MolMap_000029
MolPort-000-003-971
Mylocel
N-(Aminocarbonyl) Hydroxyamine
N-Carbamoylhydroxylamine
N-HYDROXY UREA
N-Hydroxymocovina
N-Hydroxymocovina [Czech]
N-Hydroxyurea
NCGC00015520-01
NCGC00015520-02
NCGC00015520-07
NCGC00093974-01
NCGC00093974-02
NCGC00093974-03
NCGC00093974-04
NCGC00093974-05
NCI C04831
NCI-C04831
NCI60_002773
NCIMech_000139
NHY
NINDS_000556
NSC 32065
NSC32065
Onco-Carbide
Onco-carbide
Oncocarbide
Oxyurea
S-phase/G-1 interface inhibitor
S1896_Selleck
SK 22591
SMR000059149
SPBio_000247
SPECTRUM1500344
SQ 1089
SQ-1089
Siklos
Spectrum2_000064
Spectrum3_000462
Spectrum4_000012
Spectrum5_000836
Spectrum_000909
Sterile Urea
TL8000673
UNII-X6Q56QN5QC
Ureaphil
WLN: ZVMQ
carbamide oxide
hydroxyaminomethanamide
hydroxyurea
nchembio.573-comp3
nchembio.90-comp4
nchembio749-comp3
tetratogen: inhibits ribonucleoside diphosphate reductase
2
Lapatinibapproved, investigational, Approved March 2007Phase 2294231277-92-2, 388082-78-8208908, 9941095
Synonyms:
1xkk
231277-92-2
388082-78-8
4-[[3-Chloro-4-(3-fluorobenzyloxy)phenyl]amino]-6-[5-[[(2-methanesulfonylethyl)amino]methyl]furan-2-yl]quinazoline
AB1004631
AC-1314
AC1L4LL4
AKOS005145766
CHEBI:49603
CHEMBL1201179
CHEMBL554
CID11557040
CID208908
D04024
D08108
DB01259
DB02584
EN002712
FMM
GSK 572016
GSK572016
GW 572016
GW 572016X
GW-2016
GW-572016
GW-572016F
GW2016
GW572016
HMS2089H10
I01-1247
 
Kinome_3684
Kinome_3685
LAPATINIB DITOSYLATE MONOHYDRATE
LS-187029
LS-187771
Lapatinib
Lapatinib (INN)
Lapatinib Ditosylate
Lapatinib [INN]
Lapatinib ditosylate
Lapatinib ditosylate (USAN)
Lapatinib tosilate hydrate
Lapatinib tosilate hydrate (JAN)
Lapatinib, Tykerb, GW572016
N-(3-Chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-((2-methylsulfonylethylamino)methyl)-2-furyl)quinazolin-4-amine
N-(3-Chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine
N-(3-chloro-4-((3-Fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine
N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine
N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE
N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine
NCGC00167507-01
NSC745750
TL80090051
Tycerb
Tykerb
Tykerb (TN)
Tyverb
UNII-0VUA21238F
lapatinib
lapatinib ditosylate
nchembio866-comp20
3interferonsPhase 21930
4Iron-Dextran ComplexPhase 267
5Protein Kinase InhibitorsPhase 23162
6Interferon-alphaPhase 21028
7Nucleic Acid Synthesis InhibitorsPhase 23836
8Immunologic FactorsPhase 218483
9Anti-Infective AgentsPhase 217220
10Antiviral AgentsPhase 28071
11
Pioglitazoneapproved, investigationalPhase 1419111025-46-84829
Synonyms:
(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
(+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
(+/-)-5-[[4-[2-(5-Ethyl-2-pyridinyl)-ethoxy]phenyl]methyl]-2,4-thiazolidinedione
(+/-)-5-[p-[2-(ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione
105355-27-9
111025-46-8
198077-89-3
2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]- (9CI)
5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione
5-(4-(2-(5-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione
5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione
5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione
5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione
5-[[4-[2-[(5-ethyl-2-pyridyl)]ethoxy]phenyl]methyl]thiazolidine- 2,4-dione
5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione
AB1004597
AC-1021
AC1L1J1Q
AD 4833
AD-4833
Actos
Actos (TN)
Actost
BRD-A48430263-003-02-4
BSPBio_002723
C07675
C19H20N2O3S
CHEBI:8228
CHEMBL595
CID4829
D08378
DB01132
Duetact
Glustin
HMS2089H14
HS-0047
 
HSDB 7322
I06-0089
KBio2_002103
KBio2_004671
KBio2_007239
KBio3_001943
KBioGR_001619
KBioSS_002103
LS-151327
MolPort-002-508-211
NCGC00163128-01
NCGC00163128-02
Pioglitazona
Pioglitazona [INN-Spanish]
Pioglitazone
Pioglitazone HCl
Pioglitazone Hydrochloride
Pioglitazone [BAN:INN]
Pioglitazone [Ban:Inn]
Pioglitazone [INN:BAN]
Pioglitazonum
Pioglitazonum [INN-Latin]
SPBio_001897
Spectrum2_001679
Spectrum3_001002
Spectrum4_001130
Spectrum5_001480
Spectrum5_002067
Spectrum_001623
U 72107
U 72107A
U-72107
U72,107A
UNII-X4OV71U42S
Zactos
nchembio790-comp10
pioglitazone (INN)
pioglitazone HCl
12Hypoglycemic AgentsPhase 14503

Interventional clinical trials:

(show all 12)
idNameStatusNCT IDPhase
1Stereotactic Body Radiotherapy for Spine TumorsActive, not recruitingNCT01347307Phase 4
2SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain TumorsActive, not recruitingNCT00517959Phase 3
3Radiotherapy or Radiosurgery Compared With Observation Alone in Treating Patients With Newly Diagnosed, Benign Meningioma That Has Been Partially Removed by SurgeryTerminatedNCT00104936Phase 3
4S9811 Hydroxyurea in Treating Patients With Unresectable Benign MeningiomaCompletedNCT00003590Phase 2
5Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant MeningiomasCompletedNCT00002965Phase 2
6Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related TumorsCompletedNCT00973739Phase 2
7Multisession Radiosurgery for Optic Nerve Sheath MeningiomasRecruitingNCT02594709Phase 2
8Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain TumorsCompletedNCT01151670Phase 1
9A Family Study of Adults With GliomaCompletedNCT00339352
10Analysis of NF2 Mutations in Radiation-Related Neural TumorsCompletedNCT00340496
11A Case-Referent Study of Brain Tumors in AdultsCompletedNCT00339300
12Risk Factors for Adult-Onset Brain TumorsEnrolling by invitationNCT00592865

Search NIH Clinical Center for Benign Meningioma

Genetic Tests for Benign Meningioma

About this section

Anatomical Context for Benign Meningioma

About this section

MalaCards organs/tissues related to Benign Meningioma:

33
Brain, Endothelial, Breast, Smooth muscle, Kidney, T cells, Skin

Animal Models for Benign Meningioma or affiliated genes

About this section

MGI Mouse Phenotypes related to Benign Meningioma:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes

Publications for Benign Meningioma

About this section

Articles related to Benign Meningioma:

(show all 41)
idTitleAuthorsYear
1
Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation. (26262501)
2016
2
Myoepithelioma-like Tumor of the Vulvar Region Presenting as a Nonmyxoid Spindle-Cell Neoplasm: A Potential Histologic Mimicker of Solitary Fibrous Tumor. (26959696)
2016
3
Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma. (26163879)
2015
4
Polymorphisms in the vascular endothelial growth factor gene associated with recurrent spontaneous miscarriage. (23211130)
2013
5
Patterns of myoinvasion in endometrial adenocarcinoma: recognition and implications. (23574770)
2013
6
Extracting actionable findings of appendicitis from radiology reports using natural language processing. (24303268)
2013
7
Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy. (23664235)
2013
8
Response to Comment on "Intravenous Sodium Bicarbonate Therapy in Severely Acidotic Diabetic Ketoacidosis" (24311726)
2013
9
Urethral obstruction and age of cats. (24443761)
2013
10
3-hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate against HIV type 1 entry by targeting both viral envelope glycoprotein gp120 and cellular receptor CD4. (23711095)
2013
11
Long bone fracture as a complication following external skeletal fixation: 11 cases. (23145463)
2012
12
Cost-utility analysis of different treatments for post-traumatic stress disorder in sexually abused children. (22490433)
2012
13
Predictors for pathologically confirmed aortitis after resection of the ascending aorta: a 12-year Danish nationwide population-based cross-sectional study. (21676237)
2011
14
Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma. (20503457)
2010
15
Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism. (20138963)
2010
16
C-reactive protein, interleukin 6, fibrinogen and risk of sudden death in European middle-aged men: the PRIME study. (20651278)
2010
17
Bilateral full thickness macular holes in association with serpiginous choroiditis. (19831565)
2009
18
Hysteroscopic treatment of atypical polypoid adenomyoma diagnosed incidentally in a young infertile woman. (17706212)
2008
19
Atypical teratoid rhabdoid tumor (AT/RT) in adults: review of four cases. (18369529)
2008
20
Severe renal complications in chronic myelomonocytic leukemia. (18651553)
2008
21
Absence of an association between Mycobacterium tuberculosis genotype and clinical features in children with tuberculous meningitis. (17195699)
2007
22
Expression of human beta defensin-2 in normal and various periodontitis-involved gingiva]. (16525603)
2006
23
Simultaneous evaluation of circulating chemokine and cytokine profiles in elderly subjects by multiplex technology: relationship with zinc status. (16967203)
2006
24
Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis. (16042235)
2005
25
Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia. (15161635)
2004
26
Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia. (15197801)
2004
27
Human small breast epithelial mucin: the promise of a new breast tumor biomarker. (15684711)
2004
28
Treatment of simple hyperopia: comparison of laser in situ keratomileusis and laser thermal keratoplasty. (12781275)
2003
29
The plasminogen activating system in periodontal health and disease. (11928825)
2002
30
Vasoactive treatment for hearing preservation in acoustic neuroma surgery. (11702866)
2001
31
The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. (11342595)
2001
32
Casein kinase I associates with members of the centaurin-alpha family of phosphatidylinositol 3,4,5-trisphosphate-binding proteins. (11278595)
2001
33
Suramin inhibits proliferation of human arterial smooth muscle cells in vitro: potential drug for prevention of restenosis by local drug delivery. (10834498)
2000
34
Conserved features of Y RNAs revealed by automated phylogenetic secondary structure analysis. (9927741)
1999
35
Bcr-abl translocation: diagnostic methods and clinical value]. (9754223)
1998
36
Skin autografts in epidermodysplasia verruciformis: human papillomavirus-associated cutaneous changes need over 20 years for malignant conversion. (9331078)
1997
37
A founder mutation in the gamma-sarcoglycan gene of Gypsies possibly predating their migration out of India. (8968757)
1996
38
Changes of creatine kinase secondary structure induced by the release of nucleotides from caged compounds. An infrared difference-spectroscopy study. (8797846)
1996
39
Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non-reproductive human tissues. (8529206)
1995
40
The natural history of oligohydramnios/polyhydramnios sequence in monochorionic diamniotic twins. (12796928)
1992
41
Clinical and immunological studies in pulmonary extrinsic allergic alveolitis. (Watson Prize Lecture, Royal College of Physicians and Surgeons, Glasgow, 4 April 1977). (152974)
1978

Variations for Benign Meningioma

About this section

Expression for genes affiliated with Benign Meningioma

About this section
Search GEO for disease gene expression data for Benign Meningioma.

Pathways for genes affiliated with Benign Meningioma

About this section

GO Terms for genes affiliated with Benign Meningioma

About this section

Sources for Benign Meningioma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet